Erlotinib (150mg)
Zyceva 150 mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
30 tablets in 1 strip
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zyceva 150 mg Tablet is to be taken empty stomach.
Zyceva 150 mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Zyceva 150 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Zyceva 150 mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
It is not known whether Zyceva 150 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Zyceva 150 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Zyceva 150 mg Tablet is recommended.
Use of this medicine is not advised in patients with severe kidney disease.
Zyceva 150 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Zyceva 150 mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Zyceva 150 mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
